GW810781

DB16032InvestigationalSmall molecule

GW810781 is under investigation in clinical trial NCT00046332 (A Study Comparing 4 Doses of GW810781 Versus Placebo in Hiv-infected Patients).

Chemical structure of GW810781
Mechanism
Curator reviewed
Formula / weight
C16H12FN3O3 · 313.288 g/mol (avg)
Code names
GSK-S-1360 · GW-810781 · S-1360

Resolves to

Compound
UNIIW7KQU075CVCAS280571-30-4ChEMBLCHEMBL218227
Structure
InChIKeyHFHDGHOGHWXXDT-ZSOIEALJSA-NSMILESO\C(=C/C(=O)C1=CC=C(CC2=CC=C(F)C=C2)O1)C1=NNC=N1
Targets
Q7ZJM1polP03366gag-pol

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with GW810781, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In